Skip to main content
. 2006 Jul 17;103(30):11306–11311. doi: 10.1073/pnas.0510085103

Fig. 3.

Fig. 3.

Reduced cell proliferation, invasive, and metastatic capacity of anti-TER ribozyme-expressing B16 cells. (A) Growth curves measuring cell counts over 96 h for pooled vector, pooled ribozyme (Rz), and ribozyme clone 5 cells. (B) Quantitation of tumor cell invasion into Matrigel. (C) Total tumor counts in the lungs of mice i.v. injected with pooled vector, pooled ribozyme, and ribozyme clone 5 B16 cells.

HHS Vulnerability Disclosure